Metri Bio — first-in-class therapeutics for endometrial disease

Metri Bio CEO and co-founder Ashley Abel is co-first author of a new review in Nature Biomedical Engineering on endometrial modeling and endometriosis. The paper traces how endometrial models have evolved, from early 2D cell cultures to next-generation or

In a new op-ed for the Boston Herald, Metri Bio CEO and co-founder Ashley Abel argues that endometriosis is almost certainly not one disease, and that treating it as one has kept care stuck in place for decades. Drawing on the research she began at Yale,

Metri Bio has appointed Michele Keough as Chief Operating Officer, bringing more than two decades of experience building and scaling biotechnology organizations. Across leadership roles in research strategy, operations, and alliance management, Michele ha

The Metri team at the Women's Health Summit Throughout the second quarter of 2026, Metri Bio contributed to conversations shaping the future of biotechnology, women's health, and endometriosis research. CEO and co-founder Ashley Abel represented the compa

Metri Bio has welcomed Michael S. Rogers, PhD, to its Scientific Advisory Board. Dr. Rogers is an Associate Professor of Surgery at Harvard Medical School and a principal investigator in the Vascular Biology Program at Boston Children's Hospital, where hi

The Jackson Laboratory's feature on EndoRISE highlights Connecticut's first-in-the-nation, state-supported effort to accelerate endometriosis research, care, education, and awareness. Metri Bio co-founder Ashley Abel appears in the story alongside researc

In "Immovable Object, Meet Unstoppable Force," Pillar VC's Thomas de Vlaam reflects on the scientific complexity of endometriosis, the scale of its unmet need, and the convergence of people and technology behind Metri Bio. The article traces Ashley Abel's

Metri Bio CEO and co-founder Ashley Abel has been selected for the 2026 Termeer Fellowship, a highly competitive leadership program for emerging life sciences CEOs. Through mentorship, peer learning, and access to an experienced network of biotechnology l

HealthyWomen spoke with Metri Bio CEO and co-founder Ashley Abel about the scientific insight that inspired the company, the limitations of existing endometriosis models, and Metri's work to build patient-derived human tissue models for discovering target

Metri Bio CEO and co-founder Ashley Abel has been named to the Forbes 30 Under 30 list in recognition of her work advancing new therapeutic approaches for endometriosis and other endometrial diseases. Read on forbes The post Metri Bio's CEO, Ashley Abel,